Telehealth and Monitoring for Maternal Morbidity
(MOMs-CC Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to test two levels of telehealth support to determine their effectiveness in reducing severe maternal morbidity (serious childbirth-related complications). Participants will receive either a high-touch approach with frequent health monitoring and support or a low-touch approach with less frequent interactions. The MOMs Chat and Care Study seeks Black and Hispanic pregnant individuals who have a history of pre-eclampsia or other risk factors and are less than 17 weeks pregnant. To determine if this trial is suitable, visit the trial's website for more information. As an unphased trial, this study offers a unique opportunity to contribute to important research that could improve maternal health outcomes.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.
What prior data suggests that this integrated care model is safe for maternal morbidity?
Research has shown that integrated care models, like the one used in the MOMs Chat and Care Study, are generally safe and well-received. The study includes two methods: MOMs High-Touch (MOMs-HT) and MOMs Low-Touch (MOMs-LT). Both methods involve regular check-ins and support through telehealth, using tools like chatbots and Fitbits.
These methods have been used in other settings without major safety issues. They focus on monitoring and support, rather than medication or medical procedures, making them less likely to cause side effects. Participants receive guidance and support, which helps manage health issues effectively.
In past studies on similar care models, unwanted effects were rare. Most people found the extra monitoring and support helpful. This suggests that the MOMs program is a safe choice for those considering joining the trial.12345Why are researchers excited about this trial?
Researchers are excited about the MOMs Chat and Care treatments because they offer a fresh approach to managing maternal morbidity through enhanced telehealth and digital support. Unlike traditional care, which often relies on in-person visits and standard monitoring, MOMs-HT provides intensive support with weekly chatbot check-ins and comprehensive telehealth sessions, along with tools like a blood pressure monitor and Fitbit to track health metrics. MOMs-LT, while less intensive, still offers regular digital communication and activity tracking, ensuring continuous support. This combination of advanced technology and personalized care has the potential to improve outcomes by making health monitoring and support more accessible and responsive to individual needs throughout pregnancy and postpartum.
What evidence suggests that this trial's treatments could be effective for reducing maternal morbidity?
Research has shown that the MOMs High-Touch (MOMs-HT) approach, a treatment arm in this trial, reduces serious health problems in mothers. An early study with 2,500 participants significantly lowered hospital visits for these issues. This approach includes weekly chats and online doctor visits to monitor health and connect patients with necessary services. It also provides tools like home blood pressure monitors and fitness trackers. These steps aim to offer timely care and support for pregnant women at higher risk.12346
Who Is on the Research Team?
Stephanie L Fitzpatrick, PhD
Principal Investigator
Northwell Health
Are You a Good Fit for This Trial?
This trial is for high-risk Black birthing individuals to test care models aimed at reducing severe maternal morbidity (SMM). Participants will be randomly assigned to a 'High-Touch' or 'Low-Touch' group, receiving different levels of care intensity.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Prenatal Treatment
Participants receive clinical and behavioral health monitoring via chatbot technology and telehealth visits. MOMs-HT includes 12 bi-weekly self-management support telehealth visits during the prenatal period.
Postpartum Follow-up
Participants continue to receive bi-weekly telehealth visits with navigation to clinical, behavioral, and social services up to 6 weeks postpartum.
Extended Follow-up
Participants are monitored for severe maternal morbidity and other outcomes up to 1 year postpartum.
What Are the Treatments Tested in This Trial?
Interventions
- MOMs Chat and Care Study
Trial Overview
The study compares two approaches: MOMs High-Touch with more frequent support and MOMs Low-Touch with less. It includes chats, telehealth visits, home blood pressure monitoring, and Fitbit use to track health outcomes.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants randomized to the MOMs-HT arm will receive close clinical and behavioral health monitoring via weekly chats (text or email) using chatbot technology and navigation to timely clinical, behavioral health, and/or social care services by the MOMs team throughout the prenatal and postpartum periods; 12 bi-weekly self-management support telehealth visits with a MOMs care management coordinator (CMC) or registered nurse (RN) during the prenatal period; home blood pressure monitor to measure their blood pressure regularly; Fitbit to track physical activity; and 5 bi-weekly telehealth visits with navigation to clinical, behavioral, and social services as needed by the MOMs team up to 6 weeks postpartum.
Participants randomized to the MOMs-LT arm will receive close clinical and behavioral health monitoring via weekly chats (text or email) using chatbot technology and navigation to timely clinical, behavioral health, and/or social care services by the MOMs team throughout the prenatal and postpartum periods; 5 bi-weekly telehealth visits with navigation to clinical, behavioral, and social services as needed by the MOMs team up to 6 weeks postpartum; and a Fitbit to track physical activity.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwell Health
Lead Sponsor
National Institute of Nursing Research (NINR)
Collaborator
Published Research Related to This Trial
Citations
Study Details | NCT06335381 | MOMs Chat and Care Study
The purpose of this study is to test the effectiveness of an integrated care model approach at two different levels of intensity designed to facilitate ...
MOMs Chat & Care Study: Rationale and design of ... - PubMed
A pragmatic, randomized clinical trial designed to test the effectiveness of an integrated care model to facilitate timely, appropriate care for high-risk ...
R01: Maternal OutcoMes Program: Testing Integrated ...
The purpose of the MOMs Chat & Care Study is to test the effectiveness of the MOMs approach at 2 levels of intensity designed to facilitate timely, appropriate ...
4.
dcricollab.dcri.duke.edu
dcricollab.dcri.duke.edu/sites/NIHKR/KR/MOMs%20Chat%20and%20Care%20Study%20Snapshot.pdfMOMs Chat and Care Study Snapshot. ...
In a preliminary analysis of data from 2500 participants, the program significantly reduced the risk of severe maternal morbidity–related hospital admissions at ...
MOMs Chat and Care Study
This is a pragmatic, randomized clinical trial designed to compare the effectiveness of an integrated care approach at differing levels of ...
Northwell Health MOMs Chat & Care Study | Support During ...
The MOMs Chat & Care Study is being conducted to understand the best way to support women during pregnancy and after delivery up to 1-year postpartum.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.